Biotechnology Market in the US 2025-2029

Report
170 Pages
January 2025
Region: United States
TechNavio
ID: 6050525

The biotechnology market in the US is forecasted to grow by USD 295.3 billion during 2024-2029, accelerating at a CAGR of 11.5% during the forecast period. The report on the biotechnology market in the US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of chronic and rare diseases, aging population and rising healthcare needs, and government support and funding.

The biotechnology market in the US is segmented as below:

By Product

Biologics
Therapeutics
Diagnostics
Industrial biotechnology
Others

By Type

Red biotechnology
White biotechnology
Green biotechnology
Grey biotechnology
Others

By Geographical Landscape

North America

This study identifies the incorporation of artificial intelligence and machine learning as one of the prime reasons driving the biotechnology market in the US growth during the next few years. Also, strategic partnerships and collaborations and shift towards personalized and precision medicine will lead to sizable demand in the market.

The report on the biotechnology market in the US covers the following areas:

Biotechnology Market in the US sizing
Biotechnology Market in the US forecast
Biotechnology Market in the US industry analysis

A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biotechnology market in the US vendors that include AbbVie Inc., Amgen Inc., Biogen Inc., BioMarin Pharmaceutical Inc., bluebird bio Inc., Eli Lilly and Co., Genentech Inc., Gilead Sciences Inc., Illumina Inc., Johnson and Johnson Inc., Moderna Inc., Pfizer Inc., Regeneron Pharmaceuticals Inc., Sarepta Therapeutics Inc., Thermo Fisher Scientific Inc., and Vertex Pharmaceuticals Inc. Also, the biotechnology market in the US analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Country Market Characteristics
Executive Summary - Chart on Market Segmentation by Product
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Company Market Positioning

2 Market Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis

4 Market Sizing

4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ billion)
Data Table on US - Market size and forecast 2024-2029 ($ billion)
Chart on US: Year-over-year growth 2024-2029 (%)
Data Table on US: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Biotechnology Market in US 2019 - 2023
Historic Market Size - Data Table on Biotechnology Market in US 2019 - 2023 ($ billion)
5.2 Product segment analysis 2019 - 2023
Historic Market Size - Product Segment 2019 - 2023 ($ billion)
5.3 Type segment analysis 2019 - 2023
Historic Market Size - Type Segment 2019 - 2023 ($ billion)

6 Qualitative Analysis

6.1 Impact of AI on Biotechnology Market in US

7 Five Forces Analysis

7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Product

8.1 Market segments
Chart on Product - Market share 2024-2029 (%)
Data Table on Product - Market share 2024-2029 (%)
8.2 Comparison by Product
Chart on Comparison by Product
Data Table on Comparison by Product
8.3 Biologics - Market size and forecast 2024-2029
Chart on Biologics - Market size and forecast 2024-2029 ($ billion)
Data Table on Biologics - Market size and forecast 2024-2029 ($ billion)
Chart on Biologics - Year-over-year growth 2024-2029 (%)
Data Table on Biologics - Year-over-year growth 2024-2029 (%)
8.4 Therapeutics - Market size and forecast 2024-2029
Chart on Therapeutics - Market size and forecast 2024-2029 ($ billion)
Data Table on Therapeutics - Market size and forecast 2024-2029 ($ billion)
Chart on Therapeutics - Year-over-year growth 2024-2029 (%)
Data Table on Therapeutics - Year-over-year growth 2024-2029 (%)
8.5 Diagnostics - Market size and forecast 2024-2029
Chart on Diagnostics - Market size and forecast 2024-2029 ($ billion)
Data Table on Diagnostics - Market size and forecast 2024-2029 ($ billion)
Chart on Diagnostics - Year-over-year growth 2024-2029 (%)
Data Table on Diagnostics - Year-over-year growth 2024-2029 (%)
8.6 Industrial biotechnology - Market size and forecast 2024-2029
Chart on Industrial biotechnology - Market size and forecast 2024-2029 ($ billion)
Data Table on Industrial biotechnology - Market size and forecast 2024-2029 ($ billion)
Chart on Industrial biotechnology - Year-over-year growth 2024-2029 (%)
Data Table on Industrial biotechnology - Year-over-year growth 2024-2029 (%)
8.7 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ billion)
Data Table on Others - Market size and forecast 2024-2029 ($ billion)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
8.8 Market opportunity by Product
Market opportunity by Product ($ billion)
Data Table on Market opportunity by Product ($ billion)

9 Market Segmentation by Type

9.1 Market segments
Chart on Type - Market share 2024-2029 (%)
Data Table on Type - Market share 2024-2029 (%)
9.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
9.3 Red biotechnology - Market size and forecast 2024-2029
Chart on Red biotechnology - Market size and forecast 2024-2029 ($ billion)
Data Table on Red biotechnology - Market size and forecast 2024-2029 ($ billion)
Chart on Red biotechnology - Year-over-year growth 2024-2029 (%)
Data Table on Red biotechnology - Year-over-year growth 2024-2029 (%)
9.4 White biotechnology - Market size and forecast 2024-2029
Chart on White biotechnology - Market size and forecast 2024-2029 ($ billion)
Data Table on White biotechnology - Market size and forecast 2024-2029 ($ billion)
Chart on White biotechnology - Year-over-year growth 2024-2029 (%)
Data Table on White biotechnology - Year-over-year growth 2024-2029 (%)
9.5 Green biotechnology - Market size and forecast 2024-2029
Chart on Green biotechnology - Market size and forecast 2024-2029 ($ billion)
Data Table on Green biotechnology - Market size and forecast 2024-2029 ($ billion)
Chart on Green biotechnology - Year-over-year growth 2024-2029 (%)
Data Table on Green biotechnology - Year-over-year growth 2024-2029 (%)
9.6 Grey biotechnology - Market size and forecast 2024-2029
Chart on Grey biotechnology - Market size and forecast 2024-2029 ($ billion)
Data Table on Grey biotechnology - Market size and forecast 2024-2029 ($ billion)
Chart on Grey biotechnology - Year-over-year growth 2024-2029 (%)
Data Table on Grey biotechnology - Year-over-year growth 2024-2029 (%)
9.7 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ billion)
Data Table on Others - Market size and forecast 2024-2029 ($ billion)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
9.8 Market opportunity by Type
Market opportunity by Type ($ billion)
Data Table on Market opportunity by Type ($ billion)

10 Customer Landscape

10.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

11 Drivers, Challenges, and Opportunity/Restraints

11.1 Market drivers
11.2 Market challenges
11.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
11.4 Market opportunities/restraints

12 Competitive Landscape

12.1 Overview
12.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
12.3 Landscape disruption
Overview on factors of disruption
12.4 Industry risks
Impact of key risks on business

13 Competitive Analysis

13.1 Companies profiled
Companies covered
13.2 Company ranking index
Company ranking index
13.3 Market positioning of companies
Matrix on companies position and classification
13.4 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
SWOT
13.5 Amgen Inc.
Amgen Inc. - Overview
Amgen Inc. - Product / Service
Amgen Inc. - Key news
Amgen Inc. - Key offerings
SWOT
13.6 Biogen Inc.
Biogen Inc. - Overview
Biogen Inc. - Product / Service
Biogen Inc. - Key news
Biogen Inc. - Key offerings
SWOT
13.7 BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc. - Overview
BioMarin Pharmaceutical Inc. - Product / Service
BioMarin Pharmaceutical Inc. - Key offerings
SWOT
13.8 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key offerings
SWOT
13.9 Genentech Inc.
Genentech Inc. - Overview
Genentech Inc. - Product / Service
Genentech Inc. - Key offerings
SWOT
13.10 Gilead Sciences Inc.
Gilead Sciences Inc. - Overview
Gilead Sciences Inc. - Product / Service
Gilead Sciences Inc. - Key news
Gilead Sciences Inc. - Key offerings
SWOT
13.11 Illumina Inc.
Illumina Inc. - Overview
Illumina Inc. - Business segments
Illumina Inc. - Key news
Illumina Inc. - Key offerings
Illumina Inc. - Segment focus
SWOT
13.12 Johnson and Johnson Inc.
Johnson and Johnson Inc. - Overview
Johnson and Johnson Inc. - Business segments
Johnson and Johnson Inc. - Key news
Johnson and Johnson Inc. - Key offerings
Johnson and Johnson Inc. - Segment focus
SWOT
13.13 Moderna Inc.
Moderna Inc. - Overview
Moderna Inc. - Product / Service
Moderna Inc. - Key offerings
SWOT
13.14 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
SWOT
13.15 Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc. - Overview
Regeneron Pharmaceuticals Inc. - Product / Service
Regeneron Pharmaceuticals Inc. - Key offerings
SWOT
13.16 Sarepta Therapeutics Inc.
Sarepta Therapeutics Inc. - Overview
Sarepta Therapeutics Inc. - Product / Service
Sarepta Therapeutics Inc. - Key offerings
SWOT
13.17 Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. - Overview
Thermo Fisher Scientific Inc. - Business segments
Thermo Fisher Scientific Inc. - Key news
Thermo Fisher Scientific Inc. - Key offerings
Thermo Fisher Scientific Inc. - Segment focus
SWOT
13.18 Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc. - Overview
Vertex Pharmaceuticals Inc. - Product / Service
Vertex Pharmaceuticals Inc. - Key offerings
SWOT

14 Appendix

14.1 Scope of the report
14.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
14.3 Currency conversion rates for US$
Currency conversion rates for US$
14.4 Research methodology
Research methodology
14.5 Data procurement
Information sources
14.6 Data validation
Data validation
14.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
14.8 Data synthesis
Data synthesis
14.9 360 degree market analysis
360 degree market analysis
14.10 List of abbreviations
List of abbreviations
Strong market position
Enhancement of alliances and partnerships
Strong geographic presence
Strong operational management
Strong geographic presence
Strong operational management
Enhancement of alliances and partnerships
Strong market position
Strong operational management
Strong infrastructure base
Strong market position
Strong infrastructure base
Growing demand for the market
Strong geographic presence
Strong market position
Capacity expansion of the market
Strong operational management
Strong geographic presence
Expansion of service business
Strong infrastructure base

List of Exhibits

Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Country Market Characteristics
Exhibits 4: Executive Summary - Chart on Market Segmentation by Product
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Company Market Positioning
Exhibits 7: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 8: Overview on criticality of inputs and factors of differentiation
Exhibits 9: Overview on factors of disruption
Exhibits 10: Impact of drivers and challenges in 2024 and 2029
Exhibits 11: Parent Market
Exhibits 12: Data Table on - Parent Market
Exhibits 13: Market characteristics analysis
Exhibits 14: Value chain analysis
Exhibits 15: Offerings of companies included in the market definition
Exhibits 16: Market segments
Exhibits 17: Chart on US - Market size and forecast 2024-2029 ($ billion)
Exhibits 18: Data Table on US - Market size and forecast 2024-2029 ($ billion)
Exhibits 19: Chart on US: Year-over-year growth 2024-2029 (%)
Exhibits 20: Data Table on US: Year-over-year growth 2024-2029 (%)
Exhibits 21: Historic Market Size - Data Table on Biotechnology Market in US 2019 - 2023 ($ billion)
Exhibits 22: Historic Market Size - Product Segment 2019 - 2023 ($ billion)
Exhibits 23: Historic Market Size - Type Segment 2019 - 2023 ($ billion)
Exhibits 24: Five forces analysis - Comparison between 2024 and 2029
Exhibits 25: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits 26: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits 27: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits 28: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits 29: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits 30: Chart on Market condition - Five forces 2024 and 2029
Exhibits 31: Chart on Product - Market share 2024-2029 (%)
Exhibits 32: Data Table on Product - Market share 2024-2029 (%)
Exhibits 33: Chart on Comparison by Product
Exhibits 34: Data Table on Comparison by Product
Exhibits 35: Chart on Biologics - Market size and forecast 2024-2029 ($ billion)
Exhibits 36: Data Table on Biologics - Market size and forecast 2024-2029 ($ billion)
Exhibits 37: Chart on Biologics - Year-over-year growth 2024-2029 (%)
Exhibits 38: Data Table on Biologics - Year-over-year growth 2024-2029 (%)
Exhibits 39: Chart on Therapeutics - Market size and forecast 2024-2029 ($ billion)
Exhibits 40: Data Table on Therapeutics - Market size and forecast 2024-2029 ($ billion)
Exhibits 41: Chart on Therapeutics - Year-over-year growth 2024-2029 (%)
Exhibits 42: Data Table on Therapeutics - Year-over-year growth 2024-2029 (%)
Exhibits 43: Chart on Diagnostics - Market size and forecast 2024-2029 ($ billion)
Exhibits 44: Data Table on Diagnostics - Market size and forecast 2024-2029 ($ billion)
Exhibits 45: Chart on Diagnostics - Year-over-year growth 2024-2029 (%)
Exhibits 46: Data Table on Diagnostics - Year-over-year growth 2024-2029 (%)
Exhibits 47: Chart on Industrial biotechnology - Market size and forecast 2024-2029 ($ billion)
Exhibits 48: Data Table on Industrial biotechnology - Market size and forecast 2024-2029 ($ billion)
Exhibits 49: Chart on Industrial biotechnology - Year-over-year growth 2024-2029 (%)
Exhibits 50: Data Table on Industrial biotechnology - Year-over-year growth 2024-2029 (%)
Exhibits 51: Chart on Others - Market size and forecast 2024-2029 ($ billion)
Exhibits 52: Data Table on Others - Market size and forecast 2024-2029 ($ billion)
Exhibits 53: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits 54: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits 55: Market opportunity by Product ($ billion)
Exhibits 56: Data Table on Market opportunity by Product ($ billion)
Exhibits 57: Chart on Type - Market share 2024-2029 (%)
Exhibits 58: Data Table on Type - Market share 2024-2029 (%)
Exhibits 59: Chart on Comparison by Type
Exhibits 60: Data Table on Comparison by Type
Exhibits 61: Chart on Red biotechnology - Market size and forecast 2024-2029 ($ billion)
Exhibits 62: Data Table on Red biotechnology - Market size and forecast 2024-2029 ($ billion)
Exhibits 63: Chart on Red biotechnology - Year-over-year growth 2024-2029 (%)
Exhibits 64: Data Table on Red biotechnology - Year-over-year growth 2024-2029 (%)
Exhibits 65: Chart on White biotechnology - Market size and forecast 2024-2029 ($ billion)
Exhibits 66: Data Table on White biotechnology - Market size and forecast 2024-2029 ($ billion)
Exhibits 67: Chart on White biotechnology - Year-over-year growth 2024-2029 (%)
Exhibits 68: Data Table on White biotechnology - Year-over-year growth 2024-2029 (%)
Exhibits 69: Chart on Green biotechnology - Market size and forecast 2024-2029 ($ billion)
Exhibits 70: Data Table on Green biotechnology - Market size and forecast 2024-2029 ($ billion)
Exhibits 71: Chart on Green biotechnology - Year-over-year growth 2024-2029 (%)
Exhibits 72: Data Table on Green biotechnology - Year-over-year growth 2024-2029 (%)
Exhibits 73: Chart on Grey biotechnology - Market size and forecast 2024-2029 ($ billion)
Exhibits 74: Data Table on Grey biotechnology - Market size and forecast 2024-2029 ($ billion)
Exhibits 75: Chart on Grey biotechnology - Year-over-year growth 2024-2029 (%)
Exhibits 76: Data Table on Grey biotechnology - Year-over-year growth 2024-2029 (%)
Exhibits 77: Chart on Others - Market size and forecast 2024-2029 ($ billion)
Exhibits 78: Data Table on Others - Market size and forecast 2024-2029 ($ billion)
Exhibits 79: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits 80: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits 81: Market opportunity by Type ($ billion)
Exhibits 82: Data Table on Market opportunity by Type ($ billion)
Exhibits 83: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 84: Impact of drivers and challenges in 2024 and 2029
Exhibits 85: Overview on criticality of inputs and factors of differentiation
Exhibits 86: Overview on factors of disruption
Exhibits 87: Impact of key risks on business
Exhibits 88: Companies covered
Exhibits 89: Company ranking index
Exhibits 90: Matrix on companies position and classification
Exhibits 91: AbbVie Inc. - Overview
Exhibits 92: AbbVie Inc. - Product / Service
Exhibits 93: AbbVie Inc. - Key news
Exhibits 94: AbbVie Inc. - Key offerings
Exhibits 95: SWOT
Exhibits 96: Amgen Inc. - Overview
Exhibits 97: Amgen Inc. - Product / Service
Exhibits 98: Amgen Inc. - Key news
Exhibits 99: Amgen Inc. - Key offerings
Exhibits 100: SWOT
Exhibits 101: Biogen Inc. - Overview
Exhibits 102: Biogen Inc. - Product / Service
Exhibits 103: Biogen Inc. - Key news
Exhibits 104: Biogen Inc. - Key offerings
Exhibits 105: SWOT
Exhibits 106: BioMarin Pharmaceutical Inc. - Overview
Exhibits 107: BioMarin Pharmaceutical Inc. - Product / Service
Exhibits 108: BioMarin Pharmaceutical Inc. - Key offerings
Exhibits 109: SWOT
Exhibits 110: Eli Lilly and Co. - Overview
Exhibits 111: Eli Lilly and Co. - Product / Service
Exhibits 112: Eli Lilly and Co. - Key offerings
Exhibits 113: SWOT
Exhibits 114: Genentech Inc. - Overview
Exhibits 115: Genentech Inc. - Product / Service
Exhibits 116: Genentech Inc. - Key offerings
Exhibits 117: SWOT
Exhibits 118: Gilead Sciences Inc. - Overview
Exhibits 119: Gilead Sciences Inc. - Product / Service
Exhibits 120: Gilead Sciences Inc. - Key news
Exhibits 121: Gilead Sciences Inc. - Key offerings
Exhibits 122: SWOT
Exhibits 123: Illumina Inc. - Overview
Exhibits 124: Illumina Inc. - Business segments
Exhibits 125: Illumina Inc. - Key news
Exhibits 126: Illumina Inc. - Key offerings
Exhibits 127: Illumina Inc. - Segment focus
Exhibits 128: SWOT
Exhibits 129: Johnson and Johnson Inc. - Overview
Exhibits 130: Johnson and Johnson Inc. - Business segments
Exhibits 131: Johnson and Johnson Inc. - Key news
Exhibits 132: Johnson and Johnson Inc. - Key offerings
Exhibits 133: Johnson and Johnson Inc. - Segment focus
Exhibits 134: SWOT
Exhibits 135: Moderna Inc. - Overview
Exhibits 136: Moderna Inc. - Product / Service
Exhibits 137: Moderna Inc. - Key offerings
Exhibits 138: SWOT
Exhibits 139: Pfizer Inc. - Overview
Exhibits 140: Pfizer Inc. - Product / Service
Exhibits 141: Pfizer Inc. - Key news
Exhibits 142: Pfizer Inc. - Key offerings
Exhibits 143: SWOT
Exhibits 144: Regeneron Pharmaceuticals Inc. - Overview
Exhibits 145: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibits 146: Regeneron Pharmaceuticals Inc. - Key offerings
Exhibits 147: SWOT
Exhibits 148: Sarepta Therapeutics Inc. - Overview
Exhibits 149: Sarepta Therapeutics Inc. - Product / Service
Exhibits 150: Sarepta Therapeutics Inc. - Key offerings
Exhibits 151: SWOT
Exhibits 152: Thermo Fisher Scientific Inc. - Overview
Exhibits 153: Thermo Fisher Scientific Inc. - Business segments
Exhibits 154: Thermo Fisher Scientific Inc. - Key news
Exhibits 155: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 156: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 157: SWOT
Exhibits 158: Vertex Pharmaceuticals Inc. - Overview
Exhibits 159: Vertex Pharmaceuticals Inc. - Product / Service
Exhibits 160: Vertex Pharmaceuticals Inc. - Key offerings
Exhibits 161: SWOT
Exhibits 162: Inclusions checklist
Exhibits 163: Exclusions checklist
Exhibits 164: Currency conversion rates for US$
Exhibits 165: Research methodology
Exhibits 166: Information sources
Exhibits 167: Data validation
Exhibits 168: Validation techniques employed for market sizing
Exhibits 169: Data synthesis
Exhibits 170: 360 degree market analysis
Exhibits 171: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the biotechnology market in us: AbbVie Inc., Amgen Inc., Biogen Inc., BioMarin Pharmaceutical Inc., bluebird bio Inc., Eli Lilly and Co., Genentech Inc., Gilead Sciences Inc., Illumina Inc., Johnson and Johnson Inc., Moderna Inc., Pfizer Inc., Regeneron Pharmaceuticals Inc., Sarepta Therapeutics Inc., Thermo Fisher Scientific Inc., and Vertex Pharmaceuticals Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is incorporation of artificial intelligence and machine learning."

According to the report, one of the major drivers for this market is the rising prevalence of chronic and rare diseases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

AbbVie Inc.
Amgen Inc.
Biogen Inc.
BioMarin Pharmaceutical Inc.
bluebird bio Inc.
Eli Lilly and Co.
Genentech Inc.
Gilead Sciences Inc.
Illumina Inc.
Johnson and Johnson Inc.
Moderna Inc.
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Sarepta Therapeutics Inc.
Thermo Fisher Scientific Inc.
Vertex Pharmaceuticals Inc.

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€2399EUR$2,500USD£1,999GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€3838EUR$4,000USD£3,199GBP

The biotechnology market in the US is segmented as below:

By Product

By Type

By Geographical Landscape

The report on the biotechnology market in the US covers the following areas:

Table of Contents

Executive Summary

Companies Mentioned (Partial List)

Related Topics

Related Reports

Biotechnology Market by Technology (Cell-Based Assays, Chromatography, DNA Sequencing), Application (Bioinformatics, Food & Agriculture, Health) - Cumulative Impact of High Inflation - Forecast 2023-2030

Biotechnology for the Non-Biotechnologist Training Course (November 10-14, 2025)

Biotech Market 2025-2029

Biohacking Market 2025-2029

Biotechnology Services Market Report 2025

About the Biotechnology Market